Normal huntingtin function: an alternative approach to Huntington's disease

Several neurological diseases are characterized by the altered activity of one or a few ubiquitously expressed cell proteins, but it is not known how these normal proteins turn into harmful executors of selective neuronal cell death. We selected huntingtin in Huntington's disease to explore this question because the dominant inheritance pattern of the disease seems to exclude the possibility that the wild-type protein has a role in the natural history of this condition. However, even in this extreme case, there is considerable evidence that normal huntingtin is important for neuronal function and that the activity of some of its downstream effectors, such as brain-derived neurotrophic factor, is reduced in Huntington's disease.

[1]  L. Ramirez,et al.  Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio. , 1998, Gene.

[2]  M. Ehrlich,et al.  Expression of the Striatal DARPP-32/ARPP-21 Phenotype in GABAergic Neurons Requires Neurotrophins In Vivo andIn Vitro , 1999, The Journal of Neuroscience.

[3]  C. Ross,et al.  Polyglutamine expansion of huntingtin impairs its nuclear export , 2005, Nature Genetics.

[4]  David J. Anderson,et al.  A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells , 1992, Neuron.

[5]  H. Paulson,et al.  RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Hayden,et al.  Huntingtin is required for normal hematopoiesis. , 2000, Human molecular genetics.

[7]  H. Lehrach,et al.  Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin , 2003, Journal of Biological Chemistry.

[8]  Lu Gan,et al.  Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. , 2005, Human molecular genetics.

[9]  Claire-Anne Gutekunst,et al.  Huntingtin-Interacting Protein HIP14 Is a Palmitoyl Transferase Involved in Palmitoylation and Trafficking of Multiple Neuronal Proteins , 2004, Neuron.

[10]  Pascal Kahlem,et al.  Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. , 2002, Journal of cell science.

[11]  A. Hackam,et al.  Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease , 2004, Cell Death and Differentiation.

[12]  Andrea Crotti,et al.  Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.

[13]  R. Dyer,et al.  Mutant protein in Huntington disease is resistant to proteolysis in affected brain , 2001, Nature Genetics.

[14]  Elena Cattaneo,et al.  Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. , 2005, Pharmacological research.

[15]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[16]  L. Raymond,et al.  Life Without Huntingtin , 1999, Journal of neurochemistry.

[17]  A. Parent,et al.  Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene , 1999, Brain Research.

[18]  Xiao-Jiang Li,et al.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease. , 2004, Trends in genetics : TIG.

[19]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[20]  O. Lindvall,et al.  Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. , 1995, Brain research. Developmental brain research.

[21]  R. Truant,et al.  Huntingtin contains a highly conserved nuclear export signal. , 2003, Human molecular genetics.

[22]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[23]  P. Pandolfi,et al.  SUMO Modification of Huntingtin and Huntington's Disease Pathology , 2004, Science.

[24]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[25]  Carlos Cepeda,et al.  Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease , 1999, Journal of neuroscience research.

[26]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[27]  S. Zeitlin,et al.  Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. , 1998, Development.

[28]  C. Blakemore,et al.  Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism , 2004, The Journal of Neuroscience.

[29]  P. Patterson,et al.  New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins , 2001, Brain Research Bulletin.

[30]  Elena Cattaneo,et al.  Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.

[31]  J. Penney,et al.  Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Claire-Anne Gutekunst,et al.  A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.

[33]  D. Rubinsztein,et al.  Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases , 2005, The Journal of cell biology.

[34]  M. Hayden,et al.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract , 1996, Nature Genetics.

[35]  L. Raymond,et al.  Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease , 2002, Neuron.

[36]  E. Arenas,et al.  Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Cattaneo,et al.  Modeling huntington’s disease in cells, flies, and mice , 2001, Molecular Neurobiology.

[38]  M. Chesselet,et al.  Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease Striatum , 2001, The Journal of Neuroscience.

[39]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[40]  H. Farmer.  A new perspective. , 1988, The Journal of the Florida Medical Association.

[41]  H. Nawa,et al.  Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. , 1994, Developmental biology.

[42]  Wilhelm Gaus,et al.  Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.

[43]  G. Mandel,et al.  Silencing the type II sodium channel gene: A model for neural-specific gene regulation , 1992, Neuron.

[44]  D. Rubinsztein,et al.  How does the Huntington's disease mutation damage cells? , 2003, Science of aging knowledge environment : SAGE KE.

[45]  G. Mengod,et al.  Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease , 2004, The Journal of Neuroscience.

[46]  D. Rigamonti,et al.  From target identification to drug screening assays for neurodegenerative diseases. , 2005, Pharmacological research.

[47]  Peter S. Harper,et al.  Huntington's disease , 1991 .

[48]  G. Bernardi,et al.  Co‐localization of brain‐derived neurotrophic factor (BDNF) and wild‐type huntingtin in normal and quinolinic acid‐lesioned rat brain , 2003, The European journal of neuroscience.

[49]  James M. Olson,et al.  Therapeutic opportunities in polyglutamine disease , 2001, Nature Medicine.

[50]  R. Goodman,et al.  Neuron-specific expression of the rat brain type II sodium channel gene is directed by upstream regulatory elements , 1990, Neuron.

[51]  A. Hackam,et al.  Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal Cells* , 2000, The Journal of Biological Chemistry.

[52]  M. MacDonald,et al.  Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. , 2003, Human molecular genetics.

[53]  D J Anderson,et al.  The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes , 1995, Science.

[54]  C. McMurray.  Huntington's disease: new hope for therapeutics , 2001, Trends in Neurosciences.

[55]  M. Barbacid,et al.  TrkB Signaling Is Required for Postnatal Survival of CNS Neurons and Protects Hippocampal and Motor Neurons from Axotomy-Induced Cell Death , 1997, The Journal of Neuroscience.

[56]  N. Hooper,et al.  The prion protein and neuronal zinc homeostasis. , 2003, Trends in biochemical sciences.

[57]  Z. Qin,et al.  Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. MacDonald,et al.  Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum , 1997, The Journal of Neuroscience.

[59]  E. Tongiorgi,et al.  Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo , 2005, Molecular and Cellular Neuroscience.

[60]  D. Harris,et al.  Copper Stimulates Endocytosis of the Prion Protein* , 1998, The Journal of Biological Chemistry.

[61]  U. Lendahl,et al.  Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice , 1995, The Journal of cell biology.

[62]  A. Reiner,et al.  Wild-type huntingtin plays a role in brain development and neuronal survival , 2007, Molecular Neurobiology.

[63]  M. MacDonald,et al.  Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. , 2000, Human molecular genetics.

[64]  J. Roh,et al.  Huntingtin is degraded to small fragments by calpain after ischemic injury☆ , 2003, Experimental Neurology.

[65]  N. Gavaldà,et al.  Brain‐derived neurotrophic factor prevents changes in Bcl‐2 family members and caspase‐3 activation induced by excitotoxicity in the striatum , 2005, Journal of neurochemistry.

[66]  D. Rigamonti,et al.  Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons* , 2002, The Journal of Biological Chemistry.

[67]  M. Hayden,et al.  Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. , 2005, Human molecular genetics.

[68]  R. Durbin,et al.  Comparative sequence analysis of the human and pufferfish Huntington's disease genes , 1995, Nature Genetics.

[69]  J. Hodgson,et al.  Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme* , 1996, The Journal of Biological Chemistry.

[70]  A. Hackam,et al.  Huntingtin Interacting Protein 1 Induces Apoptosis via a Novel Caspase-dependent Death Effector Domain* , 2000, The Journal of Biological Chemistry.

[71]  L. Goldstein,et al.  Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. , 2004, Journal of neurobiology.

[72]  Jacqueline K. White,et al.  Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. , 1999, Human molecular genetics.

[73]  R. Myers,et al.  A putative Drosophila homolog of the Huntington's disease gene. , 1999, Human molecular genetics.

[74]  A. Hackam,et al.  Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi , 2002, Nature Cell Biology.

[75]  E. Tolosa,et al.  Expression of Brain-Derived Neurotrophic Factor in Cortical Neurons Is Regulated by Striatal Target Area , 2001, The Journal of Neuroscience.

[76]  J. Gorski,et al.  Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[77]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[78]  B. Oostra,et al.  The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at Synapses , 2003, Cell.

[79]  Carlos Cepeda,et al.  Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF , 2004, Journal of neuroscience research.

[80]  H. Lehrach,et al.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.

[81]  I. Izquierdo,et al.  Cellular prion protein binds laminin and mediates neuritogenesis. , 2000, Brain research. Molecular brain research.

[82]  M. Hayden,et al.  Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. , 2003, Brain : a journal of neurology.

[83]  U. Roessmann,et al.  Neuropathological findings in Wolf-Hirschhorn (4p-) syndrome , 2004, Acta Neuropathologica.

[84]  E. Marcora,et al.  Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Ernst Haeckel,et al.  The Riddle of the Universe at the Close of the Nineteenth Century , 2007, Nature.

[86]  N W Wood,et al.  Trinucleotide repeats and neurodegenerative disease. , 2004, Brain : a journal of neurology.

[87]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[88]  Y. Barde,et al.  Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.

[89]  D. Surmeier,et al.  Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington’s Disease , 1999, The Journal of Neuroscience.

[90]  M. MacDonald,et al.  The serum‐ and glucocorticoid‐induced kinase SGK inhibits mutant huntingtin‐induced toxicity by phosphorylating serine 421 of huntingtin , 2004, The European journal of neuroscience.

[91]  D. Rubinsztein,et al.  Wild type huntingtin reduces the cellular toxicity of mutant huntingtin in mammalian cell models of Huntington's disease , 2001, Journal of medical genetics.

[92]  P. Brundin,et al.  Synaptic dysfunction in Huntington’s disease: a new perspective , 2005, Cellular and Molecular Life Sciences CMLS.

[93]  Patrik Brundin,et al.  Huntington's disease: a synaptopathy? , 2003, Trends in molecular medicine.

[94]  Michael S. Levine,et al.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice , 2000, Nature Genetics.

[95]  Berthold Göttgens,et al.  Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[96]  P. Greengard,et al.  Synapsins as mediators of BDNF-enhanced neurotransmitter release , 2000, Nature Neuroscience.

[97]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[98]  M. MacDonald,et al.  Huntingtin: Alive and Well and Working in Middle Management , 2003, Science's STKE.

[99]  Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2003 .

[100]  Jacqueline K. White,et al.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion , 1997, Nature Genetics.

[101]  M. Hayden,et al.  Wild‐type huntingtin protects neurons from excitotoxicity , 2006, Journal of neurochemistry.

[102]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[103]  R. Lindsay,et al.  The NeurotroDhins BDNF, NT‐3 and NT‐4/5 Promote Survival and Morphological and Biochemical Differentiation of Striatal Neurons In Vitro , 1995, The European journal of neuroscience.

[104]  C. Schwarz,et al.  Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways , 1998, Experimental Neurology.

[105]  E. Seeberg,et al.  Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro , 2004, Molecular and Cellular Biology.

[106]  P. Reddy,et al.  Polyglutamine-expanded Huntingtin Promotes Sensitization of N-Methyl-d-aspartate Receptors via Post-synaptic Density 95* , 2001, The Journal of Biological Chemistry.

[107]  K. Lindenberg,et al.  Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. , 2002, Molecular cell.

[108]  D. Rigamonti,et al.  Huntingtin's Neuroprotective Activity Occurs via Inhibition of Procaspase-9 Processing* , 2001, The Journal of Biological Chemistry.

[109]  J. Conner,et al.  Anterograde transport of brain-derived neurotrophic factor and its role in the brain , 1997, Nature.

[110]  Erich E Wanker,et al.  The hunt for huntingtin function: interaction partners tell many different stories. , 2003, Trends in biochemical sciences.

[111]  A. F. Neuwald,et al.  HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions. , 2000, Genome research.

[112]  M. MacDonald,et al.  The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. , 2001, Human molecular genetics.

[113]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[114]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[115]  R. Linden,et al.  Cellular prion protein transduces neuroprotective signals , 2002, The EMBO journal.

[116]  F. Hefti,et al.  Neurotrophin‐4/5 Promotes Survival and Differentiation of Rat Striatal Neurons Developing in Culture , 1994, The European journal of neuroscience.

[117]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[118]  L. Farrer,et al.  Homozygote for Huntington disease. , 1989, American journal of human genetics.

[119]  R. Raff,et al.  Neural expression of the Huntington's disease gene as a chordate evolutionary novelty. , 2003, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[120]  Fabrice P Cordelières,et al.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. , 2002, Developmental cell.

[121]  Lisa Garrett,et al.  Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA , 1998, Nature Genetics.

[122]  Charles Kooperberg,et al.  Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. , 2002, Human molecular genetics.

[123]  J. Mallet,et al.  Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. , 1999, Human gene therapy.

[124]  J. Nevins,et al.  Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription* , 2002, The Journal of Biological Chemistry.

[125]  Dale E. Bredesen,et al.  Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract* , 1998, The Journal of Biological Chemistry.

[126]  M. Mattson,et al.  Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[127]  R. Ferrante,et al.  Cdc42-interacting protein 4 binds to huntingtin: Neuropathologic and biological evidence for a role in Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[128]  A. Hackam,et al.  Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3 , 2000, The Journal of Neuroscience.

[129]  M. Hayden,et al.  Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity , 2004, Journal of Biological Chemistry.

[130]  A. Reiner,et al.  Neurons Lacking Huntingtin Differentially Colonize Brain and Survive in Chimeric Mice , 2001, The Journal of Neuroscience.

[131]  I. Ferrer,et al.  Brain-derived neurotrophic factor in Huntington disease , 2000, Brain Research.

[132]  L. Ellerby,et al.  Calpain Activation in Huntington's Disease , 2002, The Journal of Neuroscience.

[133]  K. Lee,et al.  Towards cellular receptors for prions , 2003, Reviews in medical virology.

[134]  David R. Brown.  Copper and prion disease , 2001, Brain Research Bulletin.

[135]  M. Sheng,et al.  Postsynaptic Signaling and Plasticity Mechanisms , 2002, Science.

[136]  G. Mengod,et al.  Brain‐derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease , 2005, Journal of neurochemistry.

[137]  S. Ratté,et al.  Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration , 2002, The EMBO journal.

[138]  J. Hodgson,et al.  Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. , 2001, American journal of human genetics.

[139]  M. MacDonald,et al.  Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. , 2000, Human molecular genetics.

[140]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[141]  M. MacDonald,et al.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease , 1993, Nature Genetics.

[142]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[143]  R. Vallee,et al.  Fast transport and retrograde movement of huntingtin and HAP 1 in axons , 1997, Neuroreport.

[144]  Peer Bork,et al.  HEAT repeats in the Huntington's disease protein , 1995, Nature Genetics.

[145]  R. Durbin,et al.  Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.

[146]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[147]  Martin Drozda,et al.  Depletion of wild‐type huntingtin in mouse models of neurologic diseases , 2003, Journal of neurochemistry.

[148]  Blair R. Leavitt,et al.  Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease , 2002, The Journal of Neuroscience.

[149]  J. Gusella,et al.  The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor , 2002, BMC Neuroscience.

[150]  J. Penney,et al.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.

[151]  X. Roucou,et al.  Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells , 2005, Cell Death and Differentiation.

[152]  K. Jellinger.  Huntington's Disease (3rd edn) , 2003 .

[153]  J. Kaplan,et al.  Sequence analysis of the CAG triplet repeats region in the Huntington disease gene (IT15) in several mammalian species. , 1996, Annales de genetique.

[154]  Gail Mandel,et al.  REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons , 1995, Cell.

[155]  Virginia E. Papaioannou,et al.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.